Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemostatic Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03486067
What this trial is testing

Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 183
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Large-scale testing (Phase 3)UnknownNCT02963129
What this trial is testing

Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT

Who this might be right for
Hereditary Hemorrhagic TelangiectasiaEpistaxis
Hospital Italiano de Buenos Aires 40
Not applicableStudy completedNCT02033928
What this trial is testing

Comprehensive Frailty Assessment

Who this might be right for
Myeloma, MultipleParaproteinemiasHematologic Neoplasms
Ohio State University Comprehensive Cancer Center 111
Testing effectiveness (Phase 2)Study completedNCT03773107
What this trial is testing

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Wake Forest University Health Sciences 12
Testing effectiveness (Phase 2)Study completedNCT01720875
What this trial is testing

Vorinostat, Bortezomib and Dexamethasone in Multiple Myeloma (MUKFour)

Who this might be right for
Multiple Myeloma
University of Leeds 16
Not applicableLooking for participantsNCT05259553
What this trial is testing

Biomarkers in Multiple Myeloma

Who this might be right for
Hematological PatientsNewly Diagnosed Multiple MyelomaChemotherapy
Centre Hospitalier Universitaire de Saint Etienne 70
Testing effectiveness (Phase 2)Ended earlyNCT02294357
What this trial is testing

Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 Carfilzomib

Who this might be right for
Multiple Myeloma
Oncotherapeutics 45
Not applicableStudy completedNCT03478839
What this trial is testing

Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

Who this might be right for
Generalized Arterial Calcification of InfancyAutosomal Recessive Hypophosphatemic Rickets Type2
National Human Genome Research Institute (NHGRI) 48
Large-scale testing (Phase 3)Active Not RecruitingNCT04071457
What this trial is testing

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 1,100
Early research (Phase 1)UnknownNCT04984434
What this trial is testing

Phase 1 Study of F182112 in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Dose-Escalation Study, Relapsed or Refractory Multiple Myeloma
Shandong New Time Pharmaceutical Co., LTD 68
Not applicableStudy completedNCT06610045
What this trial is testing

The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study

Who this might be right for
Multiple MyelomaCaregiver Subjective BurdenQuality of Life (QOL)
PeriPharm 400
Not applicableNot Yet RecruitingNCT06876545
What this trial is testing

"Vitamin C Deficiency in Hospitalized Adults: Systematic Screening Vs. Traditional Judgment - a Before-and-After Observational Study"

Who this might be right for
Scurvy
Internist.Ro 150
Post-approval studies (Phase 4)Study completedNCT05796557
What this trial is testing

ECMO Hemostatic Transfusions in Children

Who this might be right for
Extracorporeal Membrane Oxygenation ComplicationHemorrhageThromboembolism+1 more
Yale University 50
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Large-scale testing (Phase 3)UnknownNCT02270307
What this trial is testing

MSC and Cyclophosphamide for Acute Graft-Versus-Host Disease (aGVHD) Prophylaxis

Who this might be right for
LeukemiaMultiple Myeloma
National Research Center for Hematology, Russia 40
Early research (Phase 1)Study completedNCT03111992
What this trial is testing

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Novartis Pharmaceuticals 26
Not applicableStudy completedNCT03956836
What this trial is testing

Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy (HIPEC)

Who this might be right for
Coagulation DisorderCarcinomatosis
Hospitales Universitarios Virgen del Rocío 46
Very early researchStudy completedNCT02117115
What this trial is testing

Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic+1 more
Washington University School of Medicine 21
Not applicableStudy completedNCT04045561
What this trial is testing

Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure

Who this might be right for
Multiple Myeloma
Centre Hospitalier Universitaire de Nīmes 10
Next Page